A Multicenter Randomized Controlled Evaluation of Automated Home Monitoring and Telephonic Disease Management in Patients Recently Hospitalized for Congestive Heart Failure: The SPAN-CHF II Trial

2010 ◽  
Vol 16 (4) ◽  
pp. 285-292 ◽  
Author(s):  
Andrew Weintraub ◽  
Douglas Gregory ◽  
Ayan R. Patel ◽  
Daniel Levine ◽  
David Venesy ◽  
...  
Circulation ◽  
2004 ◽  
Vol 110 (11) ◽  
pp. 1450-1455 ◽  
Author(s):  
Carey Kimmelstiel ◽  
Daniel Levine ◽  
Kathleen Perry ◽  
Ayan R. Patel ◽  
Ara Sadaniantz ◽  
...  

2006 ◽  
Vol 54 (2) ◽  
pp. S387.2-S387
Author(s):  
C. Hornung ◽  
L. Goldberg ◽  
M. Jessup ◽  
C. Mundt ◽  
D. Yang ◽  
...  

2021 ◽  
Vol 27 (3) ◽  
pp. 146045822110309
Author(s):  
Rudin Gjeka ◽  
Kirit Patel ◽  
Chandra Reddy ◽  
Nora Zetsche

Congestive heart failure (CHF) is one of the most common diagnoses in the elderly United States Medicare (⩾ age 65) population. This patient population has a particularly high readmission rate, with one estimate of the 6-month readmission rate topping 40%. The rapid rise of mobile health (mHealth) presents a promising new pathway for reducing hospital readmissions of CHF, and, more generally, the management of chronic conditions. Using a randomized research design and a multivariate regression model, we evaluated the effectiveness of a hybrid mHealth model—the integration of remote patient monitoring with an applied health technology and digital disease management platform—on 45-day hospital readmissions for patients diagnosed with CHF. We find a 78% decrease in the likelihood of CHF hospital readmission for patients who were assigned to the digital disease management platform as compared to patients assigned to control.


Sign in / Sign up

Export Citation Format

Share Document